Gainers
- ECMOHO Limited (NASDAQ:MOHO) shares rose 47% to $0.2149 in pre-market trading.
- Vaccitech plc (NASDAQ:VACC) shares rose 25% to $5.89 in pre-market trading. Vaccitech recently posted Q2 earnings of $0.41 per share.
- AIM ImmunoTech Inc. (NYSE:AIM) rose 23.8% to $0.87 in pre-market trading. AIM Immunotech recently reported commencement of Phase 2 study of Ampligen for the treatment of pancreatic cancer.
- Snowflake Inc. (NYSE:SNOW) rose 17.4% to $187.18 in pre-market trading after the company reported better-than-expected Q2 sales results and issued product revenue guidance.
- Allarity Therapeutics, Inc. (NASDAQ:ALLR) rose 16.4% to $1.42 in pre-market trading after gaining 5% on Wednesday. Ladenburg Thalmann recently downgraded Allarity Therapeutics from Buy to Neutral.
- FREYR Battery (NYSE:FREY) rose 14.7% to $12.14 in pre-market trading. FREYR Battery entered into strategic partnership with Hana Technology.
- Athersys, Inc. (NASDAQ:ATHX) rose 13.4% to $0.2029 in pre-market trading. Athersys recently reported closing of $12 million registered direct offering.
- ATRenew Inc. (NYSE:RERE) rose 10.6% to $3.77 in pre-market trading after jumping 19% on Wednesday. ATRenew posted Q2 loss of $0.01 per share.
- Pulmatrix, Inc.(NASDAQ:PULM) rose 9.6% to $5.92 in pre-market trading after jumping around 18% on Wednesday. Pulmonx recently said it sees FY22 sales of $55 million to $60 million.
- Autodesk, Inc. (NASDAQ:ADSK) rose 9.5% to $234.86 in pre-market trading after the company reported better-than-expected Q2 results and issued FY23 guidance above estimates.
- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) shares rose 9.4% to $5.00 in pre-market trading. BYND Cannasoft recently posted Q2 sales of $207,653.
- 9F Inc. (NASDAQ:JFU) rose 9.3% to $0.47 in pre-market trading after dropping 28% on Wednesday.
- Agrify Corporation (NASDAQ:AGFY) shares rose 8.6% to $0.96 in pre-market trading. Agrify recently released financial results for the second quarter, revealing revenue of $19.3 million.
- BeiGene, Ltd. (NASDAQ:BGNE) rose 7.8% to $190.00 in pre-market trading. BeiGene recently announced acceptance of 11th regulatory submission for PD-1 Inhibitor Tislelizumab in China.
- Alaunos Therapeutics, Inc. (NASDAQ:TCRT) rose 7.7% to $2.20 in pre-market trading after jumping 20% on Wednesday. Alaunos Therapeutics recently reported better-than-expected Q2 EPS results.
- NetApp, Inc. (NASDAQ:NTAP) rose 6% to $77.20 in pre-market trading after the company reported better-than-expected Q1 results.
- Pinduoduo Inc. (NASDAQ:PDD) rose 5.6% to $56.20 in pre-market trading after gaining over 5% on Wednesday.
